TRAX Stock: Price, Earnings History and SEC Filings
First Tracks Biotherapeutics, Inc. (TRAX) last traded at $45.08, down 0.33% on the latest session and up 27.2% over the past month. In its most recent reported quarter (Jun 2026) earnings per share were $-0.95 against an analyst estimate of $-0.74, a miss of 28.4%.
$45.08 -0.33%
1 month+27.20%
52-week high$49.91
52-week low$14.72
Volume434,199
ExchangeNasdaqGS
Price data from Yahoo Finance, as of Oct 30, 2026. May be delayed.
TRAX earnings history
| Quarter | Reported | EPS | Estimate | Surprise |
|---|---|---|---|---|
| Jun 2026 | Aug 12, 2026 | $-0.95 | $-0.74 | -28.38% |
TRAX beat the analyst EPS estimate in 0 of its last 1 reported quarters. Source: Nasdaq.
Latest SEC filings for TRAX
SEC filing data is not available right now. You can search for TRAX on SEC EDGAR.
TRAX news
No recent headlines found. The live terminal has the full news feed.
About First Tracks Biotherapeutics, Inc.
First Tracks Biotherapeutics, Inc. (TRAX) is a US-listed public company on Nasdaq.